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The molecular basis of the binding of the lipophilic antifolate compound fluoronitropyrimethamine [2,4-diamino-5-(4- 
fluoro-3-nitrophenyl)-6-ethylpyrimidine] to its target enzyme dihydrofolate reductase has been investigated using a com- 
bination of 19F NMR spectroscopy and molecular mechanical calculations. 19F NMR reveals the presence of two different 
conformational states for the fluoronitropyrimethamine-lactobaciNus ca ei enzyme complex. MM2 molecular mechanical 
calculations predict restricted rotation about the CS-Cl’ bond of the ligand and this gives rise to two slowly interconvert- 
ing rotamers which are an enantiomeric pair. The results of 19F NMR spectroscopy reveal that both these isomers bind 
to the enzyme, with different affinities. There is no detectable interconversion of the bound rotamers themselves on the 
NMR timescale. The effect of the addition of co-enzyme to the sample is to reverse the preference the enzyme has for 
each rotamer. 
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1. INTRODUCTION 
Lipophilic antifolates based on the antimalarial 
agent pyrimethamine 1 (scheme 1) have been 
developed to treat tumours insensitive to the anti- 
neoplastic agent methotrexate due to an inhibition 
of the active uptake of the drug into cells [ 11. We 
have been investigating the molecular basis of the 
binding of a compound of this class, fluoronitro- 
pyrimethamine [2] [2,4-diamino-5-(4-fluoro-3- 
nitrophenyl)-6-ethylpyrimidine] 2, to its target en- 
zyme dihydrofolate reductase. By analogy with o- 
substituted biphenyls restricted rotation about the 
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CS-Cl ’ bond of the compound would be expected 
to give rise to two slowly interconverting rotamers 
which are an enantiomeric pair. Here we explore 
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the potential of NMR spectroscopy for detecting 
the bound states of the different enantiomers. 
2. MATERIALS AND METHODS 
Dihydrofolate reductase was isolated and purified from Lac- 
tobacillus cusei MTX/R [3]. Fluoronitropyrimethamine was 
synthesised by the method previously described [2]. 376 MHz 
19F spectra were obtained using a Bruker AM-400 spectrometer. 
The 0.4 ml samples contained 1.2 mM enzyme, 50 mM 
potassium phosphate, pH* 6.5, 500 mM potassium chloride, 
1 mM EDTA, 1 mM dioxan and excess fluoronitropyrimeth- 
amine in ‘Hz0 (pH* denotes a meter reading uncorrected for the 
deuterium isotope effect on the glass electrode). The two- 
dimensional exchange xperiment was carried out in the phase- 
sensitive mode using the NOESY pulse sequence [4]. 1024 data 
points were recorded in t2 for each of 64 t, values. 
3 RESULTS AND DISCUSSION 
The 19F spectrum of the fluoronitropyrimeth- 
amine-Lactobacillus casei enzyme complex has two 
signals (see fig.la). The additional intense peak 
referenced at 0 ppm is the resonance from free 
ligand. The signals marked A and B are due to 
bound compound which appears to be in slow ex- 
change with the free ligand. They represent dif- 
ferent conformations of the ligand-enzyme com- 
plex. The populations of these two conformations 
are different with the ratio of conformations A : B 
being 0.6 : 0.4. 
Restricted rotation in o-substituted biphenyls is 
well known [S] and would also be expected in o- 
substituted phenyl-pyrimidines. Molecular me- 
chanical calculations using the MM2 package [6] 
with modified Allingers force field constants [7] in- 
dicate that for free fluoronitropyrimethamine the 
rotation about the diaminopyrimidine-5-phenyl 
ring bond will be severely restricted, the highest 
energy conformation being that with the rings co- 
planar as shown in fig.2. Thus the ligand will nor- 
mally exist as two rotamers, with the nitro group 
either above or below the plane of the diamino- 
pyrimidine ring. In NMR experiments on the 
analogous compound 2,2’-bis-(acetoxymethyl)-di- 
phenyl, Meyer and Meyer [5] have detected 
separate rotamers and have estimated the rate of 
rotation to be 0.25 s-l at 94°C. We suggest hat the 
two 19F signals A and B correspond to two such 
rotamers bound to the enzyme. 
Fig. lb shows a two-dimensional 19F NOESY/ex- 
change experiment where the off diagonal cross 
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Fig.1. 376 MHz 19F spectra of the dihydrofolate reductase- 
fluoronitropyrimethamine complex recorded at 308 K. (a) One- 
dimensional spectrum; (b) 2-dimensional NOESY/exchange 
spectra. Both spectra are referenced to the free ligand signal. 
peaks indicate a transfer of magnetisation from 
one site to another. While cross peaks are observed 
between the signals for the free compound and 
those for both conformation A and’conformation 
B, no cross peaks are observed between signals A 
and B thus indicating that there is no detectable x- 
change between the two conformations themselves 
on the NMR timescale. This is in agreement with 
our model that conformers A and B arise from the 
binding of the two non-equivalent rotamers shown 
in fig.2. 
The effect of adding increasing amounts of 
NADP+ to the sample is shown in fig.3. The coen- 
zyme causes a marked perturbation of the signals A 
and B and two new resonances are seen. 
NOESY/exchange experiments with a fluoronitro- 
pyrimethamine-enzyme complex partially covered 
with NADP+ (not shown) indicate that signal B ex- 
changes sufficiently rapidly with B’ to give rise to a 
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Fig.2. MM2 molecular mechanical calculation of the potential 
energy dependence as a function of 36 10” rotations about the 
torsion angle C4-U-Cl ‘-C2’ of the fluoronitropyrimethamine 
structure. 
cross peak. This indicates that peak B becomes B’ 
(and thus A becomes A’) on addition of coenzyme. 
It is seen from fig.3 that the addition of coenzyme 
not only changes the environment of the fluorine 
nucleus in each of the rotamers, but also changes 
the populations of each rotamer bound to the en- 
zyme. The ratio of A: B changes from 0.6:0.4 in 
the binary complex to 0.3 : 0.7 in the ternary com- 
plex, indicating that the effect of the coenzyme is to 
reverse the preference the enzyme has for binding 
to each of the rotamers. 
For a normal racemic mixture of optical isomers, 
the isomers can be resolved thus allowing the in- 
dividual binding constants to be obtained for the 
individual components. In the case of a mixture of 
optical isomers resulting from rotamers which can 
interconvert slowly this provides an effectively ir- 
resolvable mixture which cannot be examined by 
this method. Here we show that NMR spectro- 
scopy can provide a direct method of determining 
the ratios of the binding constants of the two 
isomers present as an interconverting mixture. 
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Fig.3. The effect of the addition of increasing saturation of 
NADP+ to the dihydrofolate reductase-fluoronitropyrimeth- 
amine complex. Spectra were recorded at 308 K. 
We have previously shown that of the two 
rotameric forms of folinic acid (from hindered 
rotation about the bond between N5 and the for- 
my1 group) only one is bound to dihydrofolate 
reductase [8]. We now show that for a ligand with 
restricted rotation which exists as non-equivalent 
rotamers undergoing slow interconversion, both 
rotamers may bind to the target site thus interac- 
ting with different groups on the protein. Likewise 
each rotamer may have different affinities for the 
target, and these affinities for both can be perturb- 
ed by the binding of a second ligand. The lipophilic 
antifolate compounds metoprin [9] 3 and meta- 
azidopyrimethamine [2] 4 have similar chemical 
structures and would be expected to show the same 
phenomenon. It may also be the case that different 
rotamers may bind to different biological targets in 
the same way as the optical isomers of drugs such 
as d-ketamine [lo] and barbiturates [l l] bind to 
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different sites. Chemical modification to prevent 
the interconversion of rotamers allowing the syn- 
thesis of single rotamers may be used in the 
development of more selective agents. 
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